Skip to main content
Top
Published in: BMC Gastroenterology 1/2005

Open Access 01-12-2005 | Research article

The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis

Authors: Pieter CJ ter Borg, Durk Fekkes, Jan Maarten Vrolijk, Henk R van Buuren

Published in: BMC Gastroenterology | Issue 1/2005

Login to get access

Abstract

Background

In primary biliary cirrhosis (PBC) and primary sclerosing cholangitis (PSC) fatigue is a major clinical problem. Abnormal amino acid (AA) patterns have been implicated in the development of fatigue in several non-hepatological conditions but for PBC and PSC no data are available. This study aimed to identify abnormalities in AA patterns and to define their relation with fatigue.

Methods

Plasma concentrations of tyrosine, tryptophan, phenylalanine, valine, leucine and isoleucine were determined in plasma of patients with PBC (n = 45), PSC (n = 27), chronic hepatitis C (n = 22) and healthy controls (n = 73). Fatigue and quality of life were quantified using the Fisk fatigue severity scale, a visual analogue scale and the SF-36.

Results

Valine, isoleucine, leucine were significantly decreased in PBC and PSC. Tyrosine and phenylalanine were increased (p < 0.0002) and tryptophan decreased (p < 0.0001) in PBC. In PBC, but not in PSC, a significant inverse relation between tyrosine concentrations and fatigue and quality of life was found. Patients without fatigue and with good quality of life had increased tyrosine concentrations compared to fatigued patients. Multivariate analysis indicated that this relation was independent from disease activity or severity or presence of cirrhosis.

Conclusion

In patients with PBC and PSC, marked abnormalities in plasma AA patterns occur. Normal tyrosine concentrations, compared to increased concentrations, may be associated with fatigue and diminished quality of life.
Appendix
Available only for authorised users
Literature
1.
go back to reference Angulo P, Lindor KD: Primary sclerosing cholangitis. Hepatology. 1999, 30: 325-332. 10.1002/hep.510300101.CrossRefPubMed Angulo P, Lindor KD: Primary sclerosing cholangitis. Hepatology. 1999, 30: 325-332. 10.1002/hep.510300101.CrossRefPubMed
2.
3.
go back to reference Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000, 95: 760-767. 10.1016/S0002-9270(99)00916-8.CrossRefPubMed Huet PM, Deslauriers J, Tran A, Faucher C, Charbonneau J: Impact of fatigue on the quality of life of patients with primary biliary cirrhosis. Am J Gastroenterol. 2000, 95: 760-767. 10.1016/S0002-9270(99)00916-8.CrossRefPubMed
5.
go back to reference Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985, 88: 108-114.CrossRefPubMed Wiesner RH, LaRusso NF, Ludwig J, Dickson ER: Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology. 1985, 88: 108-114.CrossRefPubMed
6.
go back to reference Prince MI, James OF, Holland NP, Jones DE: Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol. 2000, 32: 368-373. 10.1016/S0168-8278(00)80385-2.CrossRefPubMed Prince MI, James OF, Holland NP, Jones DE: Validation of a fatigue impact score in primary biliary cirrhosis: towards a standard for clinical and trial use. J Hepatol. 2000, 32: 368-373. 10.1016/S0168-8278(00)80385-2.CrossRefPubMed
7.
go back to reference McGuire J, Ross GL, Price H, Mortensen N, Evans J, Castell LM: Biochemical markers for post-operative fatigue after major surgery. Brain Res Bull. 2003, 60: 125-130. 10.1016/S0361-9230(03)00021-2.CrossRefPubMed McGuire J, Ross GL, Price H, Mortensen N, Evans J, Castell LM: Biochemical markers for post-operative fatigue after major surgery. Brain Res Bull. 2003, 60: 125-130. 10.1016/S0361-9230(03)00021-2.CrossRefPubMed
8.
go back to reference Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP: Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci (Lond). 2003, 105: 213-218.CrossRef Georgiades E, Behan WM, Kilduff LP, Hadjicharalambous M, Mackie EE, Wilson J, Ward SA, Pitsiladis YP: Chronic fatigue syndrome: new evidence for a central fatigue disorder. Clin Sci (Lond). 2003, 105: 213-218.CrossRef
9.
go back to reference Butterworth RF: Neuroactive amino acids in hepatic encephalopathy. Metab Brain Dis. 1996, 11: 165-173.CrossRefPubMed Butterworth RF: Neuroactive amino acids in hepatic encephalopathy. Metab Brain Dis. 1996, 11: 165-173.CrossRefPubMed
10.
go back to reference Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994, 18 Suppl 1: S79-83.CrossRefPubMed Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF: Measuring the functional impact of fatigue: initial validation of the fatigue impact scale. Clin Infect Dis. 1994, 18 Suppl 1: S79-83.CrossRefPubMed
11.
go back to reference Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483.CrossRefPubMed Ware JEJ, Sherbourne CD: The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992, 30: 473-483.CrossRefPubMed
12.
go back to reference Fekkes D, van Dalen A, Edelman M, Voskuilen A: Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl. 1995, 669: 177-186. 10.1016/0378-4347(95)00111-U.CrossRefPubMed Fekkes D, van Dalen A, Edelman M, Voskuilen A: Validation of the determination of amino acids in plasma by high-performance liquid chromatography using automated pre-column derivatization with o-phthaldialdehyde. J Chromatogr B Biomed Appl. 1995, 669: 177-186. 10.1016/0378-4347(95)00111-U.CrossRefPubMed
14.
go back to reference Morgan MY, Milsom JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978, 19: 1068-1073.CrossRefPubMedPubMedCentral Morgan MY, Milsom JP, Sherlock S: Plasma ratio of valine, leucine and isoleucine to phenylalanine and tyrosine in liver disease. Gut. 1978, 19: 1068-1073.CrossRefPubMedPubMedCentral
15.
go back to reference Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg. 1978, 187: 343-350.CrossRefPubMedPubMedCentral Smith AR, Rossi-Fanelli F, Ziparo V, James JH, Perelle BA, Fischer JE: Alterations in plasma and CSF amino acids, amines and metabolites in hepatic coma. Ann Surg. 1978, 187: 343-350.CrossRefPubMedPubMedCentral
16.
go back to reference Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B: Tryptophan catabolism and T cell responses. Adv Exp Med Biol. 2003, 527: 27-35.CrossRefPubMed Mellor AL, Munn D, Chandler P, Keskin D, Johnson T, Marshall B, Jhaver K, Baban B: Tryptophan catabolism and T cell responses. Adv Exp Med Biol. 2003, 527: 27-35.CrossRefPubMed
17.
go back to reference Goldblatt J, James OF, Jones DE: Grip strength and subjective fatigue in patients with primary biliary cirrhosis. Jama. 2001, 285: 2196-2197. 10.1001/jama.285.17.2196.CrossRefPubMed Goldblatt J, James OF, Jones DE: Grip strength and subjective fatigue in patients with primary biliary cirrhosis. Jama. 2001, 285: 2196-2197. 10.1001/jama.285.17.2196.CrossRefPubMed
18.
go back to reference Watson JP, Jones DE, James OF, Cann PA, Bramble MG: Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study. J Gastroenterol Hepatol. 1999, 14: 1034-1040. 10.1046/j.1440-1746.1999.01968.x.CrossRefPubMed Watson JP, Jones DE, James OF, Cann PA, Bramble MG: Case report: oral antioxidant therapy for the treatment of primary biliary cirrhosis: a pilot study. J Gastroenterol Hepatol. 1999, 14: 1034-1040. 10.1046/j.1440-1746.1999.01968.x.CrossRefPubMed
19.
go back to reference Prince MI, Mitchison HC, Ashley D, Burke DA, Edwards N, Bramble MG, James OF, Jones DE: Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther. 2003, 17: 137-143. 10.1046/j.1365-2036.2003.01398.x.CrossRefPubMed Prince MI, Mitchison HC, Ashley D, Burke DA, Edwards N, Bramble MG, James OF, Jones DE: Oral antioxidant supplementation for fatigue associated with primary biliary cirrhosis: results of a multicentre, randomized, placebo-controlled, cross-over trial. Aliment Pharmacol Ther. 2003, 17: 137-143. 10.1046/j.1365-2036.2003.01398.x.CrossRefPubMed
20.
go back to reference Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB: A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology. 2001, 25: 213-223. 10.1016/S0893-133X(01)00231-7.CrossRefPubMed Verhoeff NP, Kapur S, Hussey D, Lee M, Christensen B, Psych C, Papatheodorou G, Zipursky RB: A simple method to measure baseline occupancy of neostriatal dopamine D2 receptors by dopamine in vivo in healthy subjects. Neuropsychopharmacology. 2001, 25: 213-223. 10.1016/S0893-133X(01)00231-7.CrossRefPubMed
21.
go back to reference Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L, Rui Q, Zipursky RB, Kapur S: Effects of catecholamine depletion on D(2) receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav. 2003, 74: 425-432. 10.1016/S0091-3057(02)01028-6.CrossRefPubMed Verhoeff NP, Christensen BK, Hussey D, Lee M, Papatheodorou G, Kopala L, Rui Q, Zipursky RB, Kapur S: Effects of catecholamine depletion on D(2) receptor binding, mood, and attentiveness in humans: a replication study. Pharmacol Biochem Behav. 2003, 74: 425-432. 10.1016/S0091-3057(02)01028-6.CrossRefPubMed
22.
go back to reference Avraham Y, Hao S, Mendelson S, Berry EM: Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc. 2001, 33: 2104-2110. 10.1097/00005768-200112000-00020.CrossRefPubMed Avraham Y, Hao S, Mendelson S, Berry EM: Tyrosine improves appetite, cognition, and exercise tolerance in activity anorexia. Med Sci Sports Exerc. 2001, 33: 2104-2110. 10.1097/00005768-200112000-00020.CrossRefPubMed
23.
go back to reference Owasoyo JO, Neri DF, Lamberth JG: Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med. 1992, 63: 364-369.PubMed Owasoyo JO, Neri DF, Lamberth JG: Tyrosine and its potential use as a countermeasure to performance decrement in military sustained operations. Aviat Space Environ Med. 1992, 63: 364-369.PubMed
24.
go back to reference Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ: Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999, 48: 203-209. 10.1016/S0361-9230(98)00163-4.CrossRefPubMed Deijen JB, Wientjes CJ, Vullinghs HF, Cloin PA, Langefeld JJ: Tyrosine improves cognitive performance and reduces blood pressure in cadets after one week of a combat training course. Brain Res Bull. 1999, 48: 203-209. 10.1016/S0361-9230(98)00163-4.CrossRefPubMed
25.
go back to reference Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD: Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut. 2004, 53: 587-592. 10.1136/gut.2003.016766.CrossRefPubMedPubMedCentral Forton DM, Patel N, Prince M, Oatridge A, Hamilton G, Goldblatt J, Allsop JM, Hajnal JV, Thomas HC, Bassendine M, Jones DE, Taylor-Robinson SD: Fatigue and primary biliary cirrhosis: association of globus pallidus magnetisation transfer ratio measurements with fatigue severity and blood manganese levels. Gut. 2004, 53: 587-592. 10.1136/gut.2003.016766.CrossRefPubMedPubMedCentral
Metadata
Title
The relation between plasma tyrosine concentration and fatigue in primary biliary cirrhosis and primary sclerosing cholangitis
Authors
Pieter CJ ter Borg
Durk Fekkes
Jan Maarten Vrolijk
Henk R van Buuren
Publication date
01-12-2005
Publisher
BioMed Central
Published in
BMC Gastroenterology / Issue 1/2005
Electronic ISSN: 1471-230X
DOI
https://doi.org/10.1186/1471-230X-5-11

Other articles of this Issue 1/2005

BMC Gastroenterology 1/2005 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.